Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium- or aluminum phosphate

Vaccine

Volumn 18, Issue 13, 2000, Pages 1227-1235

  Wang, Su ^a   Liu, Xu ^a   Fisher, Karen ^a   Smith, Jeffrey G ^a   Chen, Fei ^a   Tobery, Timothy W ^a   Ulmer, Jeffrey B ^a   Evans, Robert K ^a   Caulfield, Michael J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUPHOS; ALUMINUM HYDROXIDE; ALUMINUM PHOSPHATE; CALCIUM PHOSPHATE; CYTOKINE; DNA VACCINE; GAMMA INTERFERON; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 2; PLASMID DNA; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; DRUG FORMULATION; HEPATITIS B; HEPATITIS B VIRUS; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION; VIRUS HEPATITIS;

ADJUVANTS, IMMUNOLOGIC; ALUMINUM COMPOUNDS; AMINO ACID SEQUENCE; ANIMALS; CALCIUM PHOSPHATES; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION, SECONDARY; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MOLECULAR SEQUENCE DATA; PHOSPHATES; TH1 CELLS; VACCINES, DNA;

EID: 0033988549     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00391-6     Document Type: Article

References (45)

1. Ulmer J.B., Donnelly J.J., Parker S.E., Rhodes G.H., Felgner P.L., Dwarki V.J., et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 259:1993;1745-1749.
2. Donnelly J.J., Ulmer J.B., Shiver J.W., Liu M.A. DNA vaccines. Ann. Rev. Immunol. 15:1997;617-648.
3. Manickan E., Karem K.L., Rouse B.T. DNA vaccines-a modern gimmick or a boon to vaccinology. Critical Rev. Immunol. 17:1997;139-154.
4. Robinson H.L., Hunt L.A., Webster R.G. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine. 11:1993;957-960.
5. Bourne N., Stanberry L.R., Bernstein D.I., Lew D. DNA immunization against experimental genital herpes simplex virus infection. J. Infect. Dis. 173:1996;800-807.
6. Manickan E., Rouse R.J.D., Yu Z., Wire W.S., Rouse B.T. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes. J. Immunol. 155:1995;259-265.
7. McClements W.L., Armstrong M.E., Keys R.D., Liu M.A. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc. Natl. Acad. Sci. USA. 93:1996;11414-11420.
8. Boyer J.D., Ugen K.E., Wang B., Agadjanyan M., Gilbert L., Bagarazzi M.L., et al. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nature Medicine. 3:1997;526-532.
9. Tang D.C., De Vit M., Johnston S.A. Genetic immunization is a simple method for eliciting an immune response. Nature. 356:1992;152-154.
10. Xiang Z., Ertl H.C. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity. 2:1995;129-135.
11. Kim J.J., Ayyavoo V., Bagarazzi M.L., Chattergoon M.A., Dang K., Wang B., et al. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J. Immunol. 158:1997;816-826.
12. Tsuji T., Fukushima J., Hamajima K., Ishii N., Aoki I., Bukawa H., et al. HIV-1-specific cell-mediated immunity is enhanced by co-inoculation of TCA3 expression plasmid with DNA vaccine. Immunology. 90:1997;1-6.
13. Mendoza R.B., Cantwell M.J., Kipps T.J. Immunostimulatory effects of a plasmid expressing CD40 ligand (CD154) on gene immunization. J. Immunol. 159:1997;5777-5781.
14. Iwasaki A., Stiernholm B.J.N., Chan A.K., Berinstein N.L., Barber B.H. Enhanced cytotoxic T-lymphocyte responses mediated by plasmid DNA immunogens encoding co-stimulatory molecules and cytokines. J. Immunol. 158:1997;4591-4601.
15. Boyle J.S., Brady J.L., Lew A.M. Enhanced response to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature. 392:1998;408-411.
16. Gregoriadis G., Safie R., de Souza J.B. Liposome-mediated DNA vaccination. FEBS Lett. 402:1997;107-110.
17. Toda S., Ishii N., Okada E., Kusakabe K.I., Arai H., Hamajima I., et al. HIV 1 specific cell mediated immune responses induced by DNA vaccination were enhanced by mmanan coated liposomes and inhibited by anti-interferon gamma antibody. Immunology. 92:1997;111-117.
18. Sasaki S., Takashi T., Hamajima K., Fukushima J., Ishii N., Kaneko T., et al. Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1. Infection and Immunity. 65:1997;3520-3528.
19. Ulmer J.B., DeWitt C.M., Chastain M., Friedman A., Donnelly J.J., McClements W.L., et al. Enhancement of DNA vaccine potency using conventional aluminum adjuvants. Vaccine. 18:1999;18-28.
20. Hem S.L., White J.L. Structure and properties of aluminum-containing adjuvants. Powell M., Newman M. Vaccine design: The subunit and adjuvant approach. 1995;249-276 Plenum Press, New York.
21. Flarend R.E., Hem S.L., White J.L., Elmore D., Suckow M.A., Rudy A.C., et al. In vivo absorption of aluminum-containing vaccine adjuvants using 26Al. Vaccine. 15:1997;1314-1318.
22. Montgomery D.L., Shiver J.W., Leander K.R., Perry H.C., Friedman A., Martinez D., et al. Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. DNA Cell Biol. 12:1993;777-783.
23. Caulfield M.J., Shaffer D. A computer program for the evaluation of ELISA data obtained using an automated microtiter plate absorbance reader. J. Immunol. Methods. 74:1984;205-215.
24. Forsthuber T., Yip H.C., Lehmann P.V. Induction of TH1 and TH2 immunity in neonatal mice. Science. 271:1996;1728-1730.
25. Lalvani A., Brookes R., Hambleton S., Britton W.J., Hill A.V.S., McMichael A.J. Rapid effector function in CD8+ memory T cells. J. Exp. Med. 186:1997;859-865.
26. Chu R.S., Targoni O.S., Krieg A.M., Lehmann P.V., Harding C.V. CpG oligonucleotides act as adjuvants that switch on T helper (Th1) immunity. J. Exp. Med. 186:1997;1623-1631.
27. Relyveld E.H. Preparation and use of calcium phosphate adsorbed vaccines. Dev. Biol. Stand. 65:1986;131-136.
28. Mancino D., Ovary Z. Adjuvant effects of amorphous silica and of aluminium hydroxide on IgE and IgG1 antibody production in different inbred mouse strains. Int. Arch. Allergy Appl. Immunol. 61:1980;253-258.
29. Ulmer J.B., Fu T.-M., Deck R.R., Friedman A., Guan L., Dewitt C., et al. Protective CD4+ and CD8+ T cells against influenza induced by vaccination with nucleoprotein DNA. J. Virol. 72:1998;5648-5653.
30. White R.G., Coons A.H., Connolly J.M. Studies on antibody production. III. The alum granuloma. J. Exp. Med. 102:1955;73-85.
31. Corr M., Lee D.J., Carson D.A., Tighe H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. 184:1996;1555-1560.
32. Iwasaki A., Torre C., Ohashi P., Robinson H., Barber B. The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J. Immunol. 159:1997;11-14.
33. Fu T.-M., Ulmer J.B., Caulfield M.J., Deck R.R., Friedman A., Wang S., et al. Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Molecular Medicine. 3:1997;362-371.
34. Ridge J., Di Rosa F., Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature. 393:1998;474-478.
35. Bennett S., Carbone F., Karamalis F., Flabell R., Miller J., Heath W. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature. 393:1998;478-480.
36. Schoenberger S., Toes R., van der Voort E., Offringa R., Melief C. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature. 393:1998;480-483.
37. Fuller D.H., Murphy-Corb M., Barnett S., Steimer K., Haynes J.R. Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques. Vaccine. 15:1997;924-926.
38. Letvin N.L., Montefiori D.C., Yasutomi Y., Perry H.C., Davies M.E., Lekutis C., et al. Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination. Proc. Natl. Acad. Sci. USA. 94:1997;9378-9383.
39. Barnett S.W., Rajasekar S., Legg H., Doe B., Fuller D.H., Haynes J.R., et al. Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 subunit vaccine. Vaccine. 15:1997;869-973.
40. Hanke T., Blanchard T.J., Schneider J., Hannon C.M., Becker M., Gilbert S.C., et al. Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime. Vaccine. 16:1998;439-445.
41. Schneider J., Gilbert S.C., Blanchard T.J., Hanke T., Robson K.J., Hannan C.M., et al. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nature Med. 4:1998;397-402.
42. Aggerbeck H., Heron I. Adjuvanticity of aluminum hydroxide and calcium phosphate in diphtheria-tetanus vaccines-I. Vaccine. 13:1995;1360-1365.
43. Warren H.S., Vogel F.R., Chedid L.A. Current status of immunological adjuvants. Ann. Rev. Immunol. 4:1986;369-388.
44. Cox J.C., Coulter A.R. Adjuvants-a classification and review of their modes of action. Vaccine. 15:1997;248-256.
45. Clements-Mann ML, Eichelberger M, Boslego JW, Harro C, Evans RK, Ulmer JB et al. Safety and immunogenicity of influenza hemagglutinin DNA vaccine alone or with aluminum adjuvant in adult volunteers. American Society for Virology 17th Annual Meeting, Vancouver, BC (Abstract) 1998.